Literature DB >> 17539243

Urinary tract pathology in Schistosoma haematobium infected rural Nigerians.

O P G Nmorsi1, N C D Ukwandu, S Ogoinja, H O T Blackie, M A C Odike.   

Abstract

Parasitological investigation assessing the ova of Schistosoma haematobium in the urine of 138 volunteers in Ihieve-Ogben, Edo State, Nigeria revealed 43 positive results (31.2%). Children had a higher prevalence of urinary schistosomiasis 30 (41.1%) than their adult counterparts 13 (20.0%) and this difference was statistically significant (t = 8.89, p > 0.01). More volunteers had light intensity of infection 27 (19.6%) than heavy infection 16 (11.6%) and this difference was statistically significant (chi2 = 22.90, p>0.05). Ultrasonographic investigations carried out on these 43 S. haematobium infected volunteers revealed ten pathological conditions, including abnormal wall thickness 24 (55.8%), abnormal shape 30 (69.8%), irregular bladder wall 12 (27.9%), masses 10 (23.3%), pseudopolyps 2 (4.7%), echogenic particles 30 (69.8%), residual volume 12 (27.9%), calcifications 24 (55.8%), hydroureter 10 (23.3%) and hydronephrosis 8 (18.6%) when compared to control subjects which lacked bladder and kidney abnormalities. These pathological conditions were slightly more common in the volunteers with heavy infection than those with light infection, but this difference was not statistically significant (t = -2.19, p < 0.02). More pathological conditions were found in children than in adults; this finding was statistically significant (t = 3.23, p > 0.03). Hydronephrosis and hydroureter were not found in the volunteers with light intensity of infection.

Entities:  

Mesh:

Year:  2007        PMID: 17539243

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  6 in total

1.  The WHO ultrasonography protocol for assessing morbidity due to Schistosoma haematobium. Acceptance and evolution over 14 years. Systematic review.

Authors:  Robert Akpata; Andreas Neumayr; Martha C Holtfreter; Ingela Krantz; Daman D Singh; Rodrigo Mota; Susanne Walter; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2015-02-25       Impact factor: 2.289

2.  Schistosoma hematobium-associated glomerulopathy.

Authors:  S M Seck; M L Sarr; M C Dial; E F Ka
Journal:  Indian J Nephrol       Date:  2011-07

Review 3.  Schistosomiasis Morbidity Hotspots: Roles of the Human Host, the Parasite and Their Interface in the Development of Severe Morbidity.

Authors:  Patrice A Mawa; Julien Kincaid-Smith; Edridah M Tukahebwa; Joanne P Webster; Shona Wilson
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

4.  Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children.

Authors:  Mahamadou S Sissoko; Abdoulaye Dabo; Hamidou Traoré; Mouctar Diallo; Boubacar Traoré; Drissa Konaté; Boubacar Niaré; Moussa Diakité; Bourama Kamaté; Abdrahamane Traoré; Aboudramane Bathily; Amadou Tapily; Ousmane B Touré; Sarah Cauwenbergh; Herwig F Jansen; Ogobara K Doumbo
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

5.  Genetic diversity of Schistosoma haematobium parasite IS NOT associated with severity of disease in an endemic area in Sudan.

Authors:  Nagla Gasmelseed; Nhashal E Karamino; Mohammed O Abdelwahed; Anas O Hamdoun; Ahmed E Elmadani
Journal:  BMC Infect Dis       Date:  2014-08-27       Impact factor: 3.090

6.  Cytological and Wet Mount Microscopic Observations Made in Urine of Schistosoma haematobium-Infected Children: Hint of the Implication in Bladder Cancer.

Authors:  Patience B Tetteh-Quarcoo; Benjamin K Akuetteh; Irene A Owusu; Solomon E Quayson; Simon K Attah; Robert Armah; Emmanuel Afutu; Ama Afrah; Kantanka Addo-Osafo; Cecilia Smith; Richard K Gyasi; Patrick F Ayeh-Kumi
Journal:  Can J Infect Dis Med Microbiol       Date:  2019-09-02       Impact factor: 2.471

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.